Trials / Completed

CompletedNCT00768677

Topiramate for Binge Eating Disorder Among Adolescents

Open-Label Study of Topiramate for Binge Eating Disorder and Bulimia Nervosa Among Adolescents

Status: Completed
Phase: N/A
Study type: Interventional
Enrollment: —

Sponsor: The Zucker Hillside Hospital · Academic / Other
Sex: All
Age: 12 Years – 23 Years
Healthy volunteers: Not accepted

Summary

This is a study of topiramate to see whether topiramate decreases binge eating behavior among adolescents and young adults. The investigators did also checked whether topiramate affected cognitive function or not.

Conditions

Eating Disorders
Bulimia Nervosa

Interventions

Type	Name	Description
DRUG	topiramate

Timeline

Start date: 2003-07-01
First posted: 2008-10-08
Last updated: 2008-10-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00768677. Inclusion in this directory is not an endorsement.